로딩 중…
StockDiggingStockDigging

KYUNG NAM PHARM.CO.,LTD.

053950· KOSDAQ
₩1,850-4.59%
2026-06-19

Price Chart

KYUNG NAM PHARM.CO.,LTD.-43.16%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap28.91B KRW
Revenue58.98B KRW
Net Income-4.58B KRW
Total Assets176.00B KRW
Net Assets125.39B KRW
Employees260
Value
P/B0.23x
P/S0.49x
EV/EBITDA125.77x
FCF Yield-10.14%
Profitability
ROE-3.65%
ROA-2.60%
Op. Margin0.57%
Revenue Growth23.18%
Financial Health
Debt Ratio40.37%
Total Debt35.51B KRW
FCF-2.93B KRW
Cash21.93B KRW
Current Ratio1.75x
Net Debt/EBITDA40.18x
Performance
1Y Return-43.16%
1M Return-31.73%
From 52W High-66.85%
1Y MDD-61.66%
Trading
Volume54,676 shares
Foreign Own.3.24%
Per Share
EPS-521 KRW
BPS6,906 KRW

Company Info

CEO 김성곤, 조정영 (각자 대표이사)
Employees 260
Founded 1998
HQ 경상남도 의령군, KR

Kyungnam Pharm, established in 1998 and listed on KOSDAQ in 2001, adopted its current name after merging with HS Biopharm in 2010. The company manufactures and sells pharmaceuticals and health functional foods, distributing flagship products like Lemona nationwide through pharmacies and large supermarkets. It is expanding its business beyond its OTC specialist image, diversifying and growing the Lemona product line to increase sales and customer engagement through enhanced online marketing.